Back to Archived Journals » Core Evidence

Core Evidence ceased publishing in May 2022. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.

Journal Articles:

- 143 records -

Riociguat in the Treatment of Chronic Thromboembolic Pulmonary Hypertension: An Evidence-Based Review of Its Place in Therapy

Donaldson S, Ogunti R, Kibreab A, Mehari A

Core Evidence 2020, 15:31-40

Published Date: 25 August 2020

Vedolizumab in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Safety, Efficacy, and Place of Therapy

Takatsu N, Hisabe T, Higashi D, Ueki T, Matsui T

Core Evidence 2020, 15:7-20

Published Date: 1 April 2020

Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy

Bassetti M, Castaldo N, Carnelutti A, Peghin M, Giacobbe DR

Core Evidence 2019, 14:31-40

Published Date: 5 July 2019

Lomitapide: a review of its clinical use, efficacy, and tolerability

Alonso R, Cuevas A, Mata P

Core Evidence 2019, 14:19-30

Published Date: 1 July 2019

Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy

Lattanzi S, Brigo F, Cagnetti C, Verrotti A, Zaccara G, Silvestrini M

Core Evidence 2018, 13:21-31

Published Date: 8 March 2018

Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis

Eshtiaghi P, Gooderham MJ

Core Evidence 2018, 13:13-20

Published Date: 23 February 2018

Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy

Karagiannis T, Bekiari E, Tsapas A

Core Evidence 2017, 12:1-10

Published Date: 15 March 2017

Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy

Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R

Core Evidence 2016, 11:49-61

Published Date: 14 December 2016

Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy

Serratrice C, Carballo S, Serratrice J, Stirnemann J

Core Evidence 2016, 11:37-47

Published Date: 14 October 2016

Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy

Buti S, Leonetti A, Dallatomasina A, Bersanelli M

Core Evidence 2016, 11:23-36

Published Date: 1 September 2016

Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy

Margaritopoulos GA, Vasarmidi E, Antoniou KM

Core Evidence 2016, 11:11-22

Published Date: 1 July 2016

Clinical utility of tadalafil in the treatment of pulmonary arterial hypertension: an evidence-based review

Henrie AM, Nawarskas JJ, Anderson JR

Core Evidence 2015, 10:99-109

Published Date: 2 November 2015

Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis

Inomata M, Nishioka Y, Azuma A

Core Evidence 2015, 10:89-98

Published Date: 27 August 2015

Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy

Dinnel J, Moore BL, Skiver BM, Bose P

Core Evidence 2015, 10:23-38

Published Date: 13 January 2015

Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes

Edwards KL, Minze MG

Core Evidence 2015, 10:11-21

Published Date: 9 January 2015

Sipuleucel-T in the treatment of prostate cancer: an evidence-based review of its place in therapy

Graff JN, Chamberlain ED

Core Evidence 2015, 10:1-10

Published Date: 18 December 2014

Luliconazole for the treatment of fungal infections: an evidence-based review

Khanna D, Bharti S

Core Evidence 2014, 9:113-124

Published Date: 24 September 2014

Brodalumab: an evidence-based review of its potential in the treatment of moderate-to-severe psoriasis

Coimbra S, Figueiredo A, Santos-Silva A

Core Evidence 2014, 9:89-97

Published Date: 21 July 2014

Clinical utility of treprostinil in the treatment of pulmonary arterial hypertension: an evidence-based review

Buckley MS, Berry AJ, Kazem NH, Patel SA, Librodo PA

Core Evidence 2014, 9:71-80

Published Date: 20 June 2014

Development of cabozantinib for the treatment of prostate cancer [Corrigendum]

Vaishampayan UN

Core Evidence 2014, 9:69-70

Published Date: 16 May 2014

Development of cabozantinib for the treatment of prostate cancer

Vaishampayan UN

Core Evidence 2014, 9:61-67

Published Date: 23 April 2014

Eptifibatide: The evidence for its role in the management of acute coronary syndromes [Corrigendum]

Shah I, Khan SO, Malhotra S, Fischell T

Core Evidence 2014, 9:49-50

Published Date: 14 March 2014

Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis

Di Franco M, Gerardi MC, Lucchino B, Conti F

Core Evidence 2014, 9:41-48

Published Date: 12 March 2014

Micafungin: an evidence-based review of its place in therapy

de la Torre P, Reboli AC

Core Evidence 2014, 9:27-39

Published Date: 25 February 2014

Targeted therapy in triple-negative metastatic breast cancer: a systematic review and meta-analysis

Clark O, Botrel TE, Paladini L, Ferreira MB

Core Evidence 2014, 9:1-11

Published Date: 6 January 2014

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review

Schaller SJ, Fink H

Core Evidence 2013, 8:57-67

Published Date: 25 September 2013

Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia

Chavez JC, Sahakian E, Pinilla-Ibarz J

Core Evidence 2013, 8:37-45

Published Date: 16 May 2013

Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer

Golshayan AR, Antonarakis ES

Core Evidence 2013, 8:27-35

Published Date: 4 April 2013

An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II

Floccard B, Hautin E, Bouillet L, Coppere B, Allaouchiche B

Core Evidence 2012, 7:105-114

Published Date: 27 September 2012

Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency

Nakajima K, Oshida H, Muneyuki T, Kakei M

Core Evidence 2012, 7:77-91

Published Date: 19 July 2012

Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation

McCarty EJ, Dinsmore WW

Core Evidence 2012, 7:1-14

Published Date: 19 January 2012

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma

Jain S, Diefenbach C, Zain J, O'Connor OA

Core Evidence 2011, 6:43-57

Published Date: 4 April 2011

Plerixafor for autologous CD34+ cell mobilization

Huda Salman, Hillard M Lazarus

Core Evidence 2011, 6:23-29

Published Date: 8 February 2011

Romidepsin: evidence for its potential use to manage previously treated cutaneous T cell lymphoma

Brian Poligone, Janet Lin, Catherine Chung

Core Evidence 2011, 6:1-12

Published Date: 22 December 2010

Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosis

Douglas R Jeffery, Emily Poole Pharr

Core Evidence 2010, 5:107-112

Published Date: 8 December 2010

Pitavastatin: evidence for its place in treatment of hypercholesterolemia

Peter Alagona, Jr

Core Evidence 2010, 5:91-105

Published Date: 22 October 2010

Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer

Rossana Berardi, Azzurra Onofri, Mirco Pistelli, et al

Core Evidence 2010, 5:61-76

Published Date: 24 September 2010

Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillation

Renee M Sullivan, Brian Olshansky

Core Evidence 2010, 5:49-59

Published Date: 15 September 2010

Pegylated interferon alpha-2b as adjuvant treatment of Stage III malignant melanoma: an evidence-based review

Sonia Okuyama, Rene Gonzalez, Karl D Lewis

Core Evidence 2010, 5:39-48

Published Date: 1 September 2010

Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus

Kristen Kulasa, Steven Edelman

Core Evidence 2010, 5:23-37

Published Date: 13 August 2010

Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis

Eliana Krulig, Kenneth B Gordon

Core Evidence 2010, 5:11-22

Published Date: 5 July 2010

Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinson’s disease

Markos Poulopoulos, Cheryl Waters

Core Evidence 2010, 5:1-10

Published Date: 22 December 2009

Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation

Peter Deibert, Carola Xander, Hubert E Blum, et al

Core Evidence 2009, 4:247-258

Published Date: 11 December 2009

Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy

Paul Richardson, Constantine Mitsiades, Jacob Laubach, et al

Core Evidence 2009, 4:215-245

Published Date: 17 November 2009

Nilotinib for the treatment of chronic myeloid leukemia: An evidence-based review

Elias Jabbour, Jorge Cortes, Hagop Kantarjian

Core Evidence 2009, 4:207-213

Published Date: 5 October 2009

Trabectedin: the evidence for its place in therapy in the treatment of soft tissue sarcoma

Katherine A Thornton

Core Evidence 2009, 4:191-198

Published Date: 21 August 2009

Agomelatine: The evidence for its place in the treatment of depression

Daniela Eser, Thomas C Baghai, Hans-Jürgen Möller

Core Evidence 2009, 4:171-179

Published Date: 5 August 2009

Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection

Hans-Jürgen Stellbrink

Core Evidence 2009, 4:149-158

Published Date: 22 July 2009

Raltegravir: The evidence of its therapeutic value in HIV-1 infection

Kavya Ramkumar, Nouri Neamati

Core Evidence 2009, 4:131-147

Published Date: 2 July 2009

Lasofoxifene: Evidence of its therapeutic value in osteoporosis

Luigi Gennari, Daniela Merlotti, Vincenzo De Paola, Ranuccio Nuti

Core Evidence 2009, 4:113-129

Published Date: 1 July 2009

Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas

Ayman I Omar, Warren P Mason

Core Evidence 2009, 4:93-111

Published Date: 26 June 2009

Conivaptan: Evidence supporting its therapeutic use in hyponatremia

Melissa Li-Ng, Joseph G Verbalis

Core Evidence 2009, 4:83-92

Published Date: 25 June 2009

Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy

Daniel Z Lieberman, Suena H Massey

Core Evidence 2009, 4:67-82

Published Date: 25 June 2009

Eptifibatide: The evidence for its role in the management of acute coronary syndromes

Ibrahim Shah, Shakeel O Khan, Surender Malhotra, Tim Fischell

Core Evidence 2009, 4:49-65

Published Date: 18 June 2009

Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer

Hari A Deshpande, Scott Gettinger, Julie Ann Sosa

Core Evidence 2009, 4:43-48

Published Date: 10 June 2009

Indacaterol: a new once daily long-acting beta2 adrenoceptor agonist

Kai M Beeh, Jutta Beier

Core Evidence 2009, 4:37-41

Published Date: 18 June 2009

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout

Angelo L Gaffo, Kenneth G Saag

Core Evidence 2009, 4:25-36

Published Date: 23 June 2009

Exforge® (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact

Jean-Marie Krzesinski, Eric P Cohen

Core Evidence 2009, 4:1-11

Published Date: 17 June 2009

Ivabradine: the evidence of its therapeutic impact in angina

Guillaume Marquis-Gravel, Jean-Claude Tardif

Core Evidence 2008, 3:0-0

Published Date: 31 December 2008

Omalizumab: the evidence for its place in the treatment of allergic asthma

Diarmuid M. McNicholl, Liam G. Heaney

Core Evidence 2008, 3:0-0

Published Date: 31 December 2008

Prucalopride: the evidence for its use in the treatment of chronic constipation

Georges Coremans

Core Evidence 2008, 3:0-0

Published Date: 31 December 2008

Tolvaptan: the evidence for its therapeutic value in acute heart failure syndrome

Arash Aghel, W. H. Wilson Tang

Core Evidence 2008, 3:0-0

Published Date: 31 December 2008

Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus

Louise Profit, Paul Chrisp, Carole Nadin

Core Evidence 2008, 3:0-0

Published Date: 31 December 2008

Adalimumab in ankylosing spondylitis: an evidence-based review of its place in therapy

Stephanie Hennigan, Christoph Ackermann, Arthur Kavanaugh

Core Evidence 2007, 2:0-0

Published Date: 15 December 2007

Anidulafungin: an evidence-based review of its use in invasive fungal infections

Susan L. Davis, Jose A. Vazquez

Core Evidence 2007, 2:0-0

Published Date: 15 December 2007

Arzoxifene: the evidence for its development in the management of breast cancer

Lee R. Jackson, Kwok L. Cheung, Aman U. Buzdar, John F. R. Robertson

Core Evidence 2007, 2:0-0

Published Date: 15 December 2007

Paliperidone: the evidence of its therapeutic value in schizophrenia

Joshua Kantrowitz, Leslie Citrome

Core Evidence 2007, 2:0-0

Published Date: 15 December 2007

Abatacept: the evidence for its place in the treatment of rheumatoid arthritis

Marcus D. Köller

Core Evidence 2007, 2:0-0

Published Date: 15 September 2007

Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome

Mark Waterlow, Paul Chrisp

Core Evidence 2007, 2:0-0

Published Date: 15 September 2007

Pioglitazone and metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy

Giuseppe Derosa, Sibilla Anna Teresa Salvadeo

Core Evidence 2007, 2:0-0

Published Date: 15 September 2007

Eritoran: the evidence of its therapeutic potential in sepsis

Shahzad G. Raja, Gilles D. Dreyfus

Core Evidence 2007, 2:0-0

Published Date: 15 September 2007

Certolizumab pegol: an evidence-based review of its place in the treatment of Crohn’s disease

Andrea Cassinotti, Sandro Ardizzone, Gabriele Bianchi Porro

Core Evidence 2007, 2:0-0

Published Date: 15 September 2007

Infliximab: the evidence for its place in therapy in ulcerative colitis

Gert Van Assche, Séverine Vermeire, Paul Rutgeerts

Core Evidence 2007, 2:0-0

Published Date: 15 September 2007

Panitumumab: the evidence of its therapeutic potential in metastatic colorectal cancer care

Erika Martinelli, Floriana Morgillo, Teresa Troiani, Giampaolo Tortora, et al.

Core Evidence 2007, 2:0-0

Published Date: 15 June 2007

Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis

Louise Profit, Paul Chrisp

Core Evidence 2007, 2:0-0

Published Date: 15 June 2007

Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas

David B. Smith, John P. Neoptolemos

Core Evidence 2007, 2:0-0

Published Date: 15 June 2007

Maraviroc: the evidence for its potential in the management of HIV

Louise Profit

Core Evidence 2007, 2:0-0

Published Date: 15 March 2007

Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer

Sonya Haslam, Paul Chrisp

Core Evidence 2007, 2:0-0

Published Date: 15 March 2007

Etanercept in psoriasis: the evidence of its therapeutic impact

Andrew Thomson

Core Evidence 2007, 2:0-0

Published Date: 15 March 2007

Perindopril: the evidence of its therapeutic impact in hypertension

Andrew Thomson, Mary Greenacre

Core Evidence 2007, 2:0-0

Published Date: 15 March 2007

Eltrombopag: the emerging evidence of its therapeutic value in thrombocytopenia

Louise Profit

Core Evidence 2006, 1-Issues 3 & 4:0-0

Published Date: 30 June 2006

Ciclesonide in persistent asthma: the evidence of its therapeutic value

Charlotte A. Kenreigh, Linda Timm Wagner, Paul Chrisp

Core Evidence 2006, 1-Issues 3 & 4:0-0

Published Date: 30 June 2006

Aripiprazole: the evidence of its therapeutic impact in schizophrenia

William Winlow, Louise Profit, Paul Chrisp

Core Evidence 2006, 1-Issues 3 & 4:0-0

Published Date: 30 June 2006

Bortezomib: the evidence of its clinical impact in multiple myeloma

Simon Lancaster

Core Evidence 2006, 1-Issues 3 & 4:0-0

Published Date: 30 June 2006

K-111: the emerging evidence for its potential in the treatment of the metabolic syndrome

Margaret Duggan-Keen

Core Evidence 2006, 1-Issues 3 & 4:0-0

Published Date: 31 March 2006

FTY720 in multiple sclerosis: the emerging evidence of its therapeutic value

Andrew Thomson

Core Evidence 2006, 1-Issues 3 & 4:0-0

Published Date: 31 March 2006

Lapatinib: the evidence for its therapeutic value in metastatic breast cancer

Andrew Thomson

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 30 June 2005

Exubera® (inhaled insulin): an evidence-based review of its effectiveness in the management of diabetes

Louise Profit

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 30 June 2005

Topiramate: the evidence for its therapeutic value in the prevention of migraine

Carole Nadin

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 30 June 2005

Dutasteride: an evidence-based review of its clinical impact in the treatment of benign prostatic hyperplasia

Andrew Thomson

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 30 June 2005

Eplerenone: the evidence for its place in the treatment of heart failure after myocardial infarction

Carole Nadin

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 30 June 2005

Dasatinib: the emerging evidence of its potential in the treatment of chronic myeloid leukemia

Sonya Haslam

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 31 March 2005

Aliskiren in hypertension: evidence for its potential therapeutic value

Doris Peter

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 31 March 2005

Roflumilast: the evidence for its clinical potential in the treatment of chronic obstructive pulmonary disease

Linda Timm Wagner, Charlotte A. Kenreigh

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 31 March 2005